FTC Seeks To Revoke Ovation’s Acquisition Of Drug Used In Premature Infants
Agency claims Ovation acquired the only two drugs now marketed to treat a heart defect in premature babies and boosted the price by 1,300 percent.
Agency claims Ovation acquired the only two drugs now marketed to treat a heart defect in premature babies and boosted the price by 1,300 percent.